Thrombophilia and pregnancy loss: Cause or association

Thrombosis Research

Volumn 123, Issue SUPPL. 2, 2009, Pages

  Gris, Jean Christophe ^a,b,c  

^a NÎMES UNIVERSITY HOSPITAL   (France)

^b UNIV MONTPELLIER   (France)

^c DEPARTMENT OF NEUROLOGY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLOOD; FEMALE; FETUS DEATH; GENETICS; HUMAN; PREGNANCY; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; THROMBOPHILIA;

FEMALE; FETAL DEATH; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; PREGNANCY OUTCOME; THROMBOPHILIA;

EID: 65549130403     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/S0049-3848(09)70022-2     Document Type: Article

References (40)

1. Miler JR,Williamson E, Glue J, Gordon YB, Grudzinskas JG, Sikes A. Fetal loss after implantation: A prospective study. Lancet 1980(ii):554-6.
2. Edmonds DK, Lindsay KS, Miller JR,Williamson E,Wood PJ. Early embryonic mortality in women. Fertil Steril 1982; 38:447 53.
3. Whittaker PG, Taylor A, Lind T. Unexpected pregnancy loss in healthy women. Lancet 1983(I):1126-7.
4. Wilcox AJ, Weinberg CR, O'Connor JF, Baird DD, Schlatterer JP, Canfield RE, et al. Incidence of early loss in pregnancy. N Engl J Med 1988;319:189 94.
5. Gindler J, Li Z, Berry RJ, Zheng JC, Correa A, Sun XM, et al. Folic acid supplements during pregnancy and risk of miscarriage. Lancet 2001;358:796 800.
6. Maconochie N, Doyle P, Prior S. The National Women's Health Study: Assembly and description of a populationbased reproductive cohort. BMC Public Health 2004;4: 35.
7. Triplett DA, Harris EN. Antiphospholipid antibodies and reproduction. Am J Reprod Immunol 1989;21:123 32.
8. Beressi AH, Tefferi A, Silverstein MN, Petitt RM, Hoagland WC. Outcome analysis of 34 pregnancies in women with essential thrombocythemia. Arch Intern Med 1995;155: 1217-22.
9. Empson M, Lassere M, Craig J, Scott J. Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant. Cochrane Database Syst Rev 2005;18: CD002859.
10. Niittyvuopio R, Juvonen E, Kaaja R, Oksanen K, Hallman H, Timonen T, et al. Pregnancy in essential thrombocythemia: Experience with 40 pregnancies. Eur J Haematol 2004;73: 431-6.
11. Preston FE, Rosendaal FR, Walker ID, Briet E, Berntorp E, Conard J, et al. Increased fetal loss in women with heritable thrombophilia. Lancet 1996;348:913-6.
12. Rey E, Kahn SR, David M, Shrier I. Thrombophilic disorders and fetal loss: A meta-analysis. Lancet 2003;361:901-8.
13. Kovalevsky G, Gracia CR, Berlin JA, Sammel MD, Barnhart KT. Evaluation of the association between hereditary thrombophilias and recurrent pregnancy loss. A meta-analysis. Arch Intern Med 2004;164:558 63.
14. Dudding TE, Attia J. The association between adverse pregnancy outcomes and maternal factor V Leiden genotype: A meta-analysis. Thromb Haemost 2004;91: 700 11.
15. Bates SM, Greer IA, Hirsh J, Ginsberg JS. Use of antithrombotic agents during pregnancy: The seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest 2004;126(3 Suppl): 627S 644S.
16. Robertson L, Wu O, Langhorne P, Twaddle S, Clark P, Lowe GDO, et al. Thrombophilia in pregnancy: A systematic review. Br J Haematol 2005;132:171 96.
17. Bates SM, Greer IA, Pabinger I, Sofaer S, Hirsh J. Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy American College of Chest Physicians evidence-based clinical practice guidelines (8th edition). Chest 2008;133:844S 886S.
18. Middeldorp S. Thrombophilia and pregnancy complications: Cause or association? J Thromb Haemost 2007; 5(Suppl 1):276-82.
19. Rodger MA, Paidas M, McLintock C, Middeldorp S, Kahn S, Martinelli I, et al. Inherited thrombophilia and pregnancy complications revisited. Obstet Gynecol 2008; 112:320-4.
20. Di Nisio M, Peters L, Middeldorp S. Anticoagulants for the treatment of recurrent pregnancy loss in women without antiphospholipid syndrome. Cochrane Database Syst Rev 2005;18: CD004734.
21. Farquharson RG, Jauniaux E, Exalto N; on behalf of the ESHRE special interest group for early pregnancy. Updated and revised nomenclature for description of early pregnancy events. Hum Reprod 2005;20:3008 11.
22. Makikallio K, Tekay A, Jouppila P. Yolk sac and umbilicoplacental hemodynamics during early human embryonic development. Ultrasound Obstet Gynecol 1999;14:175-9.
23. Brigham SA, Conlon C, Farquharson RG. A longitudinal study of pregnancy outcome following idiopathic recurrent miscarriage. Hum Reprod 1999;14:2868 71.
24. Jauniaux E, Farquharson RG, Christiansen OB, Exalto N. Evidence-based guidelines for the investigation and medical treatment of recurrent miscarriage. Hum Reprod 2006;21:2216-22.
25. Morikawa M, Yamada H, Kato EH, Shimada S, Yamada T, Minakami H. Embryo loss pattern is predominant in miscarriages with normal chromosome karyotype among women with repeated miscarriages. Hum Reprod 2004; 19:2644-7.
26. Stephenson MD, Awartani KA, Robinson WP. Cytogenetic analysis of miscarriages from couples with recurrent miscarriages: A case control study. Hum Reprod 2002; 17:446 51.
27. Clifford K, Rai L, Regan L. Future pregnancy outcome in unexplained recurrent first trimester miscarriage. Hum Reprod 1007;12:387-9.
28. Edlow AG, Srinivas SK, Elovitz MA. Second-trimester loss and subsequent pregnancy outcomes: What is the real risk? Am J Obstet Gynecol 2007;197:581.
29. Frias Jr AE, Luikenaar RA, Sullivan AE, Lee RM, Porter TF, Branch DW, et al. Poor obstetric outcome in subsequent pregnancies in women with prior fetal death. Obstet Gynecol 2004;104(3):521-6.
30. Arck PC, Rucke M, Rose M, Szekeres-Bartho J, Douglas AJ, Pritsch M, et al. Early risk factors for miscarriage: A prospective cohort study in pregnant women. Reprod Biomed Online 2008;17:101 13.
31. Stray-Pedersen B, Stray-Pedersen S. Etiological factors and subsequent reproductive performance in 195 couples with a prior history of habitual abortion. Am J Obstet Gyncol 1984;148:140-6.
32. Gardella JR, Hill JA. Environmental toxins associated with recurrent pregnancy loss. Semin Reprod Med 2000;18: 407 24.
33. Westerlund Triche E, Hossain N. Environmental factors implicated in the causation of adverse pregnancy outcome. Semin Perinatol 2007;31:240-2.
34. Goldenberg RL, Culhane JF, Johnson DC. Maternal infection and neonatal outcomes. Clin Perinatol 2005; 32:523 59.
35. Genc MC. The role of gene environment interaction in predicting adverse pregnancy outcome. Best Pract Res Clin Obstet Gynaecol 2007;21:491 504.
36. Kist WJ, Janssen NG, Kalk JJ, Hague WM, Dekker GA, de Vries JIP. Thrombophilias and adverse pregnancy outcome a confounded problem. Thromb Haemost 2008;99:77 85.
37. Sood R, Kalloway S, Mast AE, Hillard CJ, Weiler J. Fetomaternal cross talk in the placenta vascular bed: Control of coagulation by trophoblast cells. Blood 2006; 107:3173 80.
38. Sood R, Zogg M, Westrick RJ, Guo YH, Kershen EJ, Girardi R, et al. Fetal gene defects precipitate platelet-mediated pregnancy failure in factor V Leiden mothers. J Exp Med 2007;204:1049 56.
39. Lissalde-Lavigne G, Fabbro-Peray P, Cochery-Nouvellon E, Mercier E, Ripart-Neveu S, Balducchi JP, et al. Factor V Leiden and prothrombin G20210A polymorphisms as risk factors for miscarriage during a first intended pregnancy: The matched case control "NOHA first" study. J Thromb Haemost 2005;3:2178-84.
40. Hill AB. The environment and disease: Association or causation? Proc R Soc Med 1965;58:293-300.